APOE and Alzheimer disease: The blood‐derived biomolecules correlated with CSF biomarkers in APOE ε4 carriers are related to neuro‐inflammation and lipid metabolism, which may indicate the role of APOE ε4 in AD pathophysiology and offer insights for diagnostic and therapeutic strategies for AD.